Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetyl-L-carnitine for amyotrophic lateral sclerosis
2004-004158-23Phase 2Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in amyotrophic lateral sclerosis (ALS) comparing Acetyl-L-carnitine with Placebo (2 arms). Started Aug 2007; status: completed.
02
Drugs
acetyl-l-carnitine
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2004-004158-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004158-23.